Comprehending the results of psychedelics on human brain networks is crucial to unlocking their therapeutic mechanisms. In people, throughout the roughly 6?hour duration of motion, psilocybin improves glutamate signalling and glucose metabolism19,twenty,21, broadly decreases the power of electrophysiological signals22, minimizes hemodynamic fluctua